|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61K 31/4706 | (2006.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/4706 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3454898 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17725014.9 |
| Date of filing the European patent application | 2017-05-09 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/031771 |
| Date | 2017-05-09 |
| (87) | Number | WO 2017/196854 |
| Date | 2017-11-16 |
| (30) | Number | Date | Country code |
| 201662334102 P | 2016-05-10 | US |
| (72) |
SELVARAJ, Anand , US
SMITH, Peter , US
|
| (73) |
Eisai R&D Management Co., Ltd. ,
6-10, Koishikawa 4-chome
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION |
| DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION |